A Journal of Integrative Biology explores how core-shell nanoparticles could revolutionize drug delivery systems and play a key role in advancing personalized and precision medicine.
Kluender, Ray, Natalia Rigol, Benjamin Roth, and Nicole Tempest Keller. "Core Innovation Capital: Investing in Fintech for Good." Harvard Business School Case 825-064, December 2024.
DCD, founded in 1999, stands as a pioneering force in the realm of IP Core Innovations. With a steadfast commitment to excellence since its inception, the company has navigated 25 years of dynamic ...
a plan to release a 288-core Xeon chip and a deal to build an AI supercomputer for Stability AI, among other things. The biggest news from the third annual Intel Innovation event was all about how ...
A Journal of Integrative Biology, explores how core-shell nanoparticles could revolutionize drug delivery systems and play a ...